BioHarvest Sciences Inc.
BHST
$4.21
-$0.04-0.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 34.51M | 32.72M | 30.19M | 27.70M | 25.19M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 34.51M | 32.72M | 30.19M | 27.70M | 25.19M |
| Cost of Revenue | 14.03M | 13.35M | 12.67M | 12.17M | 11.25M |
| Gross Profit | 20.48M | 19.37M | 17.52M | 15.53M | 13.94M |
| SG&A Expenses | 20.74M | 20.10M | 19.58M | 17.81M | 16.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.08M | 38.86M | 37.52M | 34.99M | 32.18M |
| Operating Income | -5.58M | -6.14M | -7.32M | -7.28M | -6.99M |
| Income Before Tax | -11.06M | -11.74M | -11.98M | -8.62M | -12.91M |
| Income Tax Expenses | 76.00K | 148.00K | 85.00K | 46.00K | 8.00K |
| Earnings from Continuing Operations | -11.14 | -11.89 | -12.06 | -8.67 | -12.91 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.14M | -11.89M | -12.06M | -8.67M | -12.91M |
| EBIT | -5.58M | -6.14M | -7.32M | -7.28M | -6.99M |
| EBITDA | -4.27M | -4.84M | -6.05M | -6.06M | -5.97M |
| EPS Basic | -0.62 | -0.69 | -0.70 | -0.50 | -0.85 |
| Normalized Basic EPS | -0.38 | -0.42 | -0.43 | -0.31 | -0.53 |
| EPS Diluted | -0.62 | -0.69 | -0.70 | -0.50 | -0.85 |
| Normalized Diluted EPS | -0.38 | -0.42 | -0.43 | -0.31 | -0.53 |
| Average Basic Shares Outstanding | 73.46M | 69.42M | 69.33M | 68.35M | 64.77M |
| Average Diluted Shares Outstanding | 73.46M | 69.42M | 69.33M | 68.35M | 64.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |